首页> 外文期刊>Der Pharma Chemica: journal for medicinal chemistry, pharmaceutical chemistry and computational chemistry >A new route for the synthesis of (R)- and (S)- 2-((2-oxooxazolidin-5- yl)methyl)isoindoline-1,3-dione: A key chiral building block
【24h】

A new route for the synthesis of (R)- and (S)- 2-((2-oxooxazolidin-5- yl)methyl)isoindoline-1,3-dione: A key chiral building block

机译:合成(R)-和(S)-2-((2-氧代恶唑啉丁-5-基)甲基)异吲哚啉-1,3-二酮的新途径:关键的手性构件

获取原文
           

摘要

A new and efficient route for the synthesis of (R)- & (S)-2-((2-oxooxazolidin-5-yl)methyl) isoindoline-1,3-dione is described. The enantiopurity of the synthesized two stereoisomers of 2- ((2-oxooxazolidin-5-yl)methyl)isoindoline-1,3-dione, is established using chiral high performance liquid chromatography (HPLC) i.e. enantiomeric excess (ee) of R & S isomers are 99.5% and 99.6% respectively. This route also involves the synthesis of a key chiral constituent, (R)- & (S)5-(chloromethyl) oxazolidin-2-one.
机译:描述了一种合成(R)-和(S)-2-(((2-氧代恶唑啉丁-5-基)甲基)异吲哚啉-1,3-二酮的新的有效途径。使用手性高效液相色谱(HPLC)(即R和R的对映体过量(ee))建立了2-((2-氧代恶唑啉丁-5-基)甲基)异吲哚啉-1,3-二酮的两种合成立体异构体的对映体纯度。 S异构体分别为99.5%和99.6%。该途径还涉及关键手性成分(R)-和(S)5-(氯甲基)恶唑烷-2--2-的合成。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号